Stocks of DexCom - Current price, Where to buy? Chart
| Detail | Data |
|---|---|
| Stocks: | DexCom |
| ompany Name: | DexCom, Inc. |
| Ticker: | DXCM |
| Exchange: | NasdaqGS |
| Outstanding stocks: | 385,515,008 |
| 24-hour Volume: | 878,761 |
| Industry: | Medical Devices |
| Sector: | Healthcare |
| Number of Employees: | 9500 |
| Country: | United States |
| City: | San Diego |
| Address: | 6340 Sequence Drive |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| 103.51 | 60.07 | 1.3 USD | 2.24 USD | 5.37 USD | 51,876,827,136.00 USD |
| P/E Ratio: | 103.51 |
|---|---|
| Forward P/E: | 60.07 |
| EPS: | 1.3 USD |
| Forward EPS: | 2.24 |
| Book value per share: | 5.37 USD |
| Market capitalization: | 51,876,827,136.00 USD |
DexCom
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 3,622,299,904.00 USD |
| Net Income: | 541,500,032.00 USD |
| Price-to-Book (P/B) Ratio: | 25.07 |
| PEG Ratio: | 2.32 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for DexCom stocks is: buy |
| Number of Analysts: | 22 |
| Highest Target Price: | 170 USD |
| Lowest Target Price: | 122 USD |
| Average Target Price: | 150 USD |
Note: The data is approximate. Recommendations and price forecasts for DexCom stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | According to our data, the company DexCom is currently not paying dividends. |
| Annual Yield %: | - |
| Ex-dividend Date: | - |
| Average % Yield for 5 Years: | - |
| Payout Ratio: | - |
| Value of Last Dividend Paid: | - |
| Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy DexCom Stocks?
If you're interested in investing in DexCom stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of DexCom stocks through mobile apps with client support. In this table, you can compare brokers offering real DexCom stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about DexCom (DXCM)
DexCom consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 3,622,299,904.00 USD, demonstrating its strong market position and ability to generate high revenues. EBITDA of 783,699,968.00 USD reflects profitable operations with potential for further improvement for DexCom. A higher debt-to-equity ratio of 1.25 indicates higher leverage for DexCom compared to its equity, requiring cautious management. Gross margin of 63.19% shows that DexCom efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Lower profit margin of 14.95% suggests opportunities for DexCom to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 3,622,299,904.00 USD |
| EBITDA: | 783,699,968.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
| Earnings Per Share: | 1.3 USD |
| Book Value Per Share: | 5.37 USD |
| Total Cash: | 2,724,100,096.00 USD |
| Total Cash per Share: | 7.07 USD |
| Total Debt: | 2,593,999,872.00 USD |
| Debt to Equity Ratio: | 1.25 |
| Quick Ratio: | 2.39 |
| Current Ratio: | 2.84 |
| Free Cash Flow: | 477,075,008.00 USD |
| Operating Cash Flow: | 748,499,968.00 USD |
| Company Margins | |
| Gross Margins: | 63.19 % |
| EBITDA Margins: | 21.64 % |
| Operating Margins: | 20.97 % |
| Profit Margins: | 14.95 % |
| Performance | |
| Return on Assets: | 6.4 % |
| Return on Equity: | 25.8 % |
| Earnings Growth (1 year): | 181.0% |
| Revenue Growth (1 year): | 26.9 % |
| Year-over-Year Quarterly Earnings Growth: | 179.2 % |
| Valuation | |
| Market Capitalization: | 51,876,827,136.00 USD |
| Enterprise Value: | 51,474,993,152.00 USD |
| EV/Revenue: | 14.211 |
| EV/EBITDA: | 65.682 |
| Number of Shares and Short Shares | |
| Float Shares: | 379,713,414 shares |
| Shares Outstanding: | 385,515,008 shares |
| Held Percent Insiders: | 0.00 % |
| Held Percent Institutions: | 103.05 % |
| Shares Short: | 14,572,039 |
| Shares Short Prior Month: | 16,648,248 |
| Date Short Interest: | 2024-03-28 |
| Shares Percent Shares Out: | 3.78 % |
| Short Ratio: | 4.32 |
| Beta: | 1.21 |
| Short Percent of Float: | 4.28 % |
| Předpokládaný počet akcií: | 385,515,008 |
Frequently Asked Questions (FAQ)
According to our data, DexCom does not currently pay dividends, even in 2024.
DexCom shares are traded on the stock exchange NasdaqGS under the ticker symbol: DXCM. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for DexCom shares by a total of 22 analysts. The average target price prediction is 150 USD per share.
The total number of DexCom shares on the exchange is 385,515,008.00, which, at the current market capitalization, values the company at 51,876,827,136.00 USD.
